Literature DB >> 32574471

Barriers to Revision Total Hip Service Lines: A Surgeon's Perspective Through a Deterministic Financial Model.

James E Feng1,2, Afshin A Anoushiravani3, Lauren H Schoof1, Jonathan A Gabor1, Jorge Padilla1,4, James Slover1, Ran Schwarzkopf1.   

Abstract

BACKGROUND: Revision THA represents approximately 5% to 10% of all THAs. Despite the complexity of these procedures, revision arthroplasty service lines are generally absent even at high-volume orthopaedic centers. We wanted to evaluate whether financial compensation is a barrier for the development of revision THA service lines as assessed by RVUs. QUESTIONS/PURPOSES: Therefore, we asked: (1) Are physicians fairly compensated for revision THA on a per-minute basis compared with primary THA? (2) Are physicians fairly compensated for revision THA on a per-day basis compared with primary THA?
METHODS: Our deterministic financial model was derived from retrospective data of all patients undergoing primary or revision THA between January 2016 and June 2018 at an academic healthcare organization. Patients were divided into five cohorts based on their surgical procedure: primary THA, head and liner exchange, acetabular component revision THA, femoral component revision THA, and combined femoral and acetabular component revision THA. Mean surgical times were calculated for each cohort, and each cohort was assigned a relative value unit (RVU) derived from the 2018 Center for Medicaid and Medicare assigned RVU fee schedule. Using a combination of mean surgical time and RVUs rewarded for each procedure, three models were developed to assess the financial incentive to perform THA services for each cohort. These models included: (1) RVUs earned per the mean surgical time, (2) RVUs earned for a single operating room for a full day of THAs, and (3) RVUs earned for two operating rooms for a full day of primary THAs versus a single rooms for a full day of revision THAs. A sixth cohort was added in the latter two models to more accurately reflect the variety in a typical surgical day. This consisted of a blend of revision THAs: one acetabular, one femoral, and one full revision. The RVUs generated in each model were compared across the cohorts.
RESULTS: Compared with primary THA by RVU per minute, in revision THA, head and liner exchange demonstrated a 4% per minute deficit, acetabular component revision demonstrated a 29% deficit, femoral component revision demonstrated a 32% deficit, and full revision demonstrated a 27% deficit. Compared with primary service lines with one room, revision surgeons with a variety of revision THA surgeries lost 26% potential relative value units per day. Compared with a two-room primary THA service, revision surgeons lost 55% potential relative value units per day.
CONCLUSIONS: In a comparison of relative value units of a typical two-room primary THA service line versus those of a dedicated revision THA service line, we found that revision specialists may lose between 28% and 55% of their RVU earnings. The current Centers for Medicare and Medicaid Services reimbursement model is not viable for the arthroplasty surgeon and limits patient access to revision THA specialists. LEVEL OF EVIDENCE: Level III, economic and decision analysis.

Entities:  

Mesh:

Year:  2020        PMID: 32574471      PMCID: PMC7310415          DOI: 10.1097/CORR.0000000000001273

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.755


  33 in total

1.  Early Results of Medicare's Bundled Payment Initiative for a 90-Day Total Joint Arthroplasty Episode of Care.

Authors:  Richard Iorio; Andrew J Clair; Ifeoma A Inneh; James D Slover; Joseph A Bosco; Joseph D Zuckerman
Journal:  J Arthroplasty       Date:  2015-09-09       Impact factor: 4.757

2.  Economic burden of revision hip and knee arthroplasty in Medicare enrollees.

Authors:  K L Ong; F S Mowat; N Chan; E Lau; M T Halpern; S M Kurtz
Journal:  Clin Orthop Relat Res       Date:  2006-05       Impact factor: 4.176

3.  Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030.

Authors:  Steven Kurtz; Kevin Ong; Edmund Lau; Fionna Mowat; Michael Halpern
Journal:  J Bone Joint Surg Am       Date:  2007-04       Impact factor: 5.284

4.  Impact of payer type on resource utilization, outcomes and access to care in total hip arthroplasty.

Authors:  Adrian Hinman; Kevin J Bozic
Journal:  J Arthroplasty       Date:  2008-09       Impact factor: 4.757

5.  Are Bundled Payments a Viable Reimbursement Model for Revision Total Joint Arthroplasty?

Authors:  P Maxwell Courtney; Blair S Ashley; Eric L Hume; Atul F Kamath
Journal:  Clin Orthop Relat Res       Date:  2016-06-29       Impact factor: 4.176

6.  Medicare fails to compensate additional surgical time and effort associated with revision arthroplasty.

Authors:  Anthony T Tokarski; Carl A Deirmengian; Paul M Lichstein; Matthew S Austin; Gregory K Deirmengian
Journal:  J Arthroplasty       Date:  2014-11-10       Impact factor: 4.757

7.  Revision total joint arthroplasty: the epidemiology of 63,140 cases in New York State.

Authors:  Ankit Bansal; Omar N Khatib; Joseph D Zuckerman
Journal:  J Arthroplasty       Date:  2013-05-13       Impact factor: 4.757

8.  ASA Physical Status and age predict morbidity after three surgical procedures.

Authors:  D J Cullen; G Apolone; S Greenfield; E Guadagnoli; P Cleary
Journal:  Ann Surg       Date:  1994-07       Impact factor: 12.969

9.  Disparity in total joint arthroplasty patient comorbidities, demographics, and postoperative outcomes based on insurance payer type.

Authors:  Christopher T Martin; John J Callaghan; Steve S Liu; Yubo Gao; Lucian C Warth; Richard C Johnston
Journal:  J Arthroplasty       Date:  2012-08-03       Impact factor: 4.757

10.  Provider Volume of Total Knee Arthroplasties and Patient Outcomes in the HCUP-Nationwide Inpatient Sample.

Authors:  Sheleika L Hervey; Harriett R Purves; Ulrich Guller; Alison P Toth; Thomas P Vail; Ricardo Pietrobon
Journal:  J Bone Joint Surg Am       Date:  2003-09       Impact factor: 5.284

View more
  3 in total

1.  The Hidden Cost of Revision Hip and Knee Arthroplasty.

Authors:  Mackenzie A Roof; Brett R Levine; Ran Schwarzkopf
Journal:  Arthroplast Today       Date:  2022-06-23

2.  Modelling Stakeholder Valuation: An Example Using the Surgical Treatments for Gastroesophageal Reflux Disease.

Authors:  Qizhi V Zheng; Vic Velanovich
Journal:  Cureus       Date:  2021-11-14

3.  Primary versus revision total shoulder arthroplasty: comparing relative value and reimbursement trends.

Authors:  John Joseph Carney; Erik Gerlach; Mark Plantz; Peter Raymond Swiatek; Jeremy Marx; Matthew Saltzman; Guido Marra
Journal:  Clin Shoulder Elb       Date:  2022-01-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.